Boardroom Alpha
S-1/A primary document
BIVI · Amended Registration Statement (Form S-1/A) · Filed August 14, 2026

Biovie Inc — S-1/A exhibit

bivi_s1a3ex5z1.htm

Exhibit 5.1

 

 

 

 

 

9275 W. Russell Road, Suite 240
Las Vegas, Nevada 89148

PH (702) 692-8026 | FX (702) 692-8075

fennemorelaw.com

  

August 14, 2026 

BioVie Inc.

680 West Nye Lane, Suite 201

Carson City, Nevada 489703

 

Re:BioVie Inc./Registration Statement on Form S-1

 

Ladies and Gentlemen:

 

We have acted as special Nevada counsel to BioVie Inc., a Nevada corporation (the “Company”), in connection with the registration, offering, issuance, and sale by the Company of: (a) an aggregate of up to $25,000,000 of (i) shares (collectively, the “Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”) and (ii) pre-funded common stock purchase warrants (collectively, the “Pre-Funded Warrants”) to purchase shares of Common Stock with an exercise price equal to $0.0001 per share, in each case together with accompanying common stock purchase warrants (collectively, the “Common Warrants”) to purchase shares of Common Stock; (b) the shares (the “Pre-Funded Warrant Shares”) issuable upon exercise of the Pre-Funded Warrants; and (c) the shares (the “Common Warrant Shares”) issuable upon exercise of the Common Warrants. The Shares, the Common Warrants, the Pre-Funded Warrants, the Pre-Funded Warrant Shares and the Common Warrant Shares are collectively referred to herein as the “Securities.”

The Securities are being offered, sold, and issued under the terms of a placement agency agreement (the “Placement Agency Agreement”) to be entered into by and between the Company and ThinkEquity LLC, as the placement agent. The Securities are being registered under a Registration Statement on Form S-1 (File No.333-297552) (the “Registration Statement”) filed with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act).

For purposes of these opinions, we have examined originals or copies, certified or otherwise identified to our satisfaction, of:

 

(a)the Registration Statement;
(b)Placement Agency Agreement;
(c)form of Common Warrant;
(d)form of Pre-Funded Warrant; and
(e)resolutions of the Board of Directors and such other matters as relevant related to the (i) issuance and the registration of the Securities under the Securities Act, and (ii) such other matters as relevant.
   

 

 

 

BioVie Inc.

August 14, 2026

Page 2

  

We have obtained from officers and agents of the Company and from public officials, and have relied upon, such certificates, representations, and assurances as we have deemed necessary and appropriate for purposes of rendering this opinion letter. We have also examined such other corporate documents, records, certificates, and instruments (collectively with the documents identified in (a) through (e) above, the “Documents”) as we deem necessary or advisable to render the opinions set forth herein.

 

In our examination, we have assumed:

(a)the legal capacity of all natural persons executing the Documents;
(b)the genuineness of all signatures on the Documents;
(c)the authenticity of all Documents submitted to us as originals, and the conformity to original documents of all Documents submitted to us as copies;
(d)that the parties to such Documents, other than the Company, had the power, corporate or other, to enter into and perform all obligations thereunder;
(e)other than with respect to the Company, the due authorization by all requisite action, corporate or other, of the Documents;
(f)the execution, delivery, and performance by all parties of the Documents; and
(g)that all Documents are valid, binding, and enforceable against the parties thereto.

We have relied upon the accuracy and completeness of the information, factual matters, representations, and warranties contained in such Documents.

 

We note that the Company has reserved, and assume that it will continue to reserve, sufficient authorized shares of its Common Stock to allow for the issuance of its shares of Common Stock upon sale of the Shares and exercise of the Pre-Funded Warrants and the Common Warrants.

 

The opinions expressed below are limited to the matters specifically set forth herein and no other opinion shall be inferred beyond the matters expressly stated. We disclaim any undertaking to advise you of any subsequent changes in the facts stated or assumed for purposes of delivering these opinions expressed herein or any changes in applicable law that may come to our attention after the date the Registration Statement is declared effective.

 

On the basis of the foregoing and in reliance thereon, and subject to the assumptions, limitations, and qualifications set forth herein, we are of the opinion that:

 

(a)the Shares have been duly authorized, and when issued against payment in accordance with the terms of the Placement Agency Agreement, will be validly issued, fully paid, and nonassessable;

 

(b)the Pre-Funded Warrant Shares have been duly authorized, and when issued upon exercise of the Pre-Funded Warrants in accordance with the terms thereof, will be validly issued, fully paid, and non-assessable; and

 

(c)the Common Warrant Shares have been duly authorized, and when issued upon exercise of the Common Warrants in accordance with the terms thereof, will be validly issued, fully paid, and non-assessable.

 

   

 

 

 

BioVie Inc.

August 14, 2026

Page 3

 

While certain members of this firm are admitted to practice in certain jurisdictions other than Nevada, in rendering the foregoing opinions we have not examined the laws of any jurisdiction other than Nevada. Accordingly, we express no opinion regarding the effect of the laws of any other jurisdiction or state, including any federal laws. The opinions we express herein are limited solely to the laws of the State of Nevada, other than the securities laws and regulations of the State of Nevada as to which we express no opinion.

 

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and we consent to the reference of our name under the caption “Legal Matters” in the Registration Statement. In giving the foregoing consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.

 

 

Very truly yours,

 

/s/ Fennemore Craig, P.C.

 

Fennemore Craig, P.C.

 

tmor/cdol

 

   
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer